Specifically, we introduced a codon-optimized, CRISPR-resistant exogenous CDK7 construct designed to evade recognition by the targeting gRNAs, into three HNSCC cell lines from our panel. The gene discussed is CDK7; the disease is head and neck squamous cell carcinoma.